Synthesis of 3H-labeled N-(3-iodoprop-2E-enyl)-2β-carbomethoxy-3β-(4-methylphenyl)nortropane (PE2I) and its interaction with mice striatal membrane fragments

Applied Radiation and Isotopes

Volumn 65, Issue 3, 2007, Pages 293-300

  Stepanov, Vladimir ^a,b   Schou, Magnus ^b   Järv, Jaak ^a   Halldin, Christer ^b  

^a UNIVERSITY OF TARTU   (Estonia)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Dopamine transporter; Radioligand; Tritium labeled PE2I

Indexed keywords

AMINES; CARBON; IODINE; RADIOACTIVITY; TRITIUM;

BINDING SITES; DOPAMINE TRANSPORTER; RADIOLIGAND BINDING; SEROTONIN; STRIATAL MEMBRANES;

SYNTHESIS (CHEMICAL);

CARBON 11; DOPAMINE TRANSPORTER; IODINE 125; LIGAND; N (3 IODOPROP 2 ENYL( 2BETA CARBOMETHOXY 3BETA (4 METHYLPHENYL)NORTROPANE H 3; NORADRENALIN TRANSPORTER; NORTROPANE DERIVATIVE; RADIOLIGAND; SEROTONIN TRANSPORTER; TRITIUM; N (3 IODOPROP 2 ENYL) 2 BETA CARBOMETHOXY 3 (4 METHYLPHENYL)NORTROPANE; N-(3-IODOPROP-2-ENYL)-2-BETA-CARBOMETHOXY-3-(4-METHYLPHENYL)NORTROPANE; RADIOPHARMACEUTICAL AGENT;

ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN MEMBRANE; CORPUS STRIATUM; DRUG SELECTIVITY; DRUG SYNTHESIS; FEMALE; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTUM YIELD; ANIMAL; CELL MEMBRANE; METABOLISM; METHODOLOGY; SYNTHESIS;

ANIMALS; CELL MEMBRANE; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; ISOTOPE LABELING; MICE; NORTROPANES; RADIOPHARMACEUTICALS; TRITIUM;

EID: 33845678645     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2006.09.003     Document Type: Article

References (20)

1. Carroll F.I., Gao Y.G., Rahman M.A., Abraham P., Parham K., Lewin A.H., Boja J.W., and Kuhar M.J. Synthesis, ligand binding, QSAR, and CoMFA study of 3 beta-(p-substituted phenyl)tropane-2 beta-carboxylic acid methyl esters. J. Med. Chem. 34 9 (1991) 2719-2725
2. Chalon S., Garreau L., Emond P., Zimmer L., Vilar M.-P., Besnard J.-C., and Guilloteau D. Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4′-methylphenyl)nortropane as a selective and potent inhibitor of the neuronal dopamine transporter. J. Pharmacol. Exp. Ther. 291 3 (1999) 648-654
3. Ciliax B.J., Heilman C., Demchyshyn L.L., Pristupa Z.B., Ince E., Hersch S.M., Niznik H.B., and Levey A.I. The dopamine transporter: immunochemical characterization and localization in brain. J. Neurosci. 15 3 Pt 1 (1995) 1714-1723
4. Clarke R.L., Daum S.J., Gambino A.J., Aceto M.D., Pearl J., Levitt M., Cumiskey W.R., and Bogado E.F. Compounds affecting the central nervous system. 4. 3 Beta-phenyltropane-2-carboxylic esters and analogs. J. Med. Chem 16 11 (1973) 1260-1267
5. Emond P., Garreau L., Chalon S., Boazi M., Caillet M., Bricard J., Frangin Y., Mauclaire L., Besnard J.C., and Guilloteau D. Synthesis and ligand binding of nortropane derivatives: N-substituted 2beta-carbomethoxy-3beta-(4′-iodophenyl)nortropane and N-(3-iodoprop-(2E)-enyl)-2beta-carbomethoxy-3beta-(3',4'-disubstituted phenyl)nortropane. New high-affinity and selective compounds for the dopamine transporter. J. Med. Chem. 40 9 (1997) 1366-1372
6. Freed C., Revay R., Vaughan R.A., Kriek E., Grant S., Uhl G.R., and Kuhar M.J. Dopamine transporter immunoreactivity in rat brain. J. Comp. Neurol. 359 2 (1995) 340-349
7. Gobel J., Saussy D.L., and Goetz A.S. Development of scintillation-proximity assays for alpha adrenoceptors. J. Pharmacol. Toxicol. 42 4 (1999) 237-244
8. Goodman M.M., Kung M.P., Kabalka G.W., Kung H.F., and Switzer R. Synthesis and characterization of radioiodinated N-(3-iodopropen-1-yl)-2 beta-carbomethoxy-3 beta-(4-chlorophenyl)tropanes: potential dopamine reuptake site imaging agents. J. Med. Chem. 37 10 (1994) 1535-1542
9. Guilloteau D., Emond P., Baulieu J.L., Garreau L., Frangin Y., Pourcelot L., Mauclaire L., Besnard J.C., and Chalon S. Exploration of the dopamine transporter: in vitro and in vivo characterization of a high-affinity and high-specificity iodinated tropane derivative: (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-methylphenyl)nortropane (PE2I). Nucl. Med. Biol. 25 4 (1998) 331-337
10. Hall H., Halldin C., Guilloteau D., Chalon S., Emond P., Besnard J., Farde L., and Sedvall G. Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [125I]PE2I. Neuroimage 9 1 (1999) 108-116
11. Halldin C., Farde L., Lundkvist C., Ginovart N., Nakashima Y., Karlsson P., and Swahn C.-G. [11C]beta-CIT-FE, a radioligand for quantitation of the dopamine transporter in the living brain using positron emission tomography. Synapse 22 4 (1996) 386-390
12. Halldin C., Gulyas B., Langer O., and Farde L. Brain radioligands-state of the art and new trends. Q. J. Nucl. Med. 45 2 (2001) 139-152
13. Halldin C., Erixon-Lindroth N., Pauli S., Chou Y.H., Okubo Y., Karlsson P., Lundkvist C., Olsson H., Guilloteau D., Emond P., and Farde L. [(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain. Eur J. Nucl. Med. Mol. Imag. 30 9 (2003) 1220-1230
14. Jucaite A., Fernell E., Halldin C., Forssberg H., and Farde L. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. Biol. Psychiatry 57 3 (2005) 229-238
15. Jung M.E., and Light L.A. Preparation of iodoallylic alcohols via hydrostannylation: spectroscopic proof of structures. Tetrahedron Lett. 23 38 (1982) 3851-3854
16. Kuhar M.J., Sanchez-Roa P.M., Wong D.F., Dannals R.F., Grigoriadis D.E., Lew R., and Milberger M. Dopamine transporter: biochemistry, pharmacology and imaging. Eur. Neurol. 30 Suppl. 1 (1990) 15-20
17. Kuikka J.T., Baulieu J.L., Hiltunen J., Halldin C., Bergstrom K.A., Farde L., Emond P., Chalon S., Yu M., Nikula T., and Laitinen T. Pharmacokinetics and dosimetry of iodine-123 labelled PE2I in humans, a radioligand for dopamine transporter imaging. Eur. J. Nucl. Med. 25 5 (1998) 531-534
18. Neumeyer J.L., Wang S.Y., Milius R.A., Baldwin R.M., Zea-Ponce Y., Hoffer P.B., Sybirska E., Al-Tikriti M., Charney D.S., and Malison R.T. [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brain. J. Med. Chem. 34 10 (1991) 3144-3146
19. Newman A.H., and Kulkarni S. Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic-a focus on analogues of benztropine and rimcazole. Med. Res. Rev. 22 5 (2002) 429-464
20. Swahn C.-G., Halldin C., Günther I., Patt J., and Ametamey S. Synthesis of unlabelled, 3H- and 125I-labelled β-CIT and its ω-fluoroalkyl analogues β-CIT-FE and β-CIT-FP, including synthesis of precursors. J. Laboratory Comp. Radiopharm. 38 7 (1996) 675-685